Clinical Trial Update: Intranasal Sufentanil for Analgesia of Severe Sickle Cell Vaso-occlusive Pain Crisis in the Pediatric [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating intranasal sufentanil for analgesia in pediatric severe sickle cell vaso-occlusive crisis; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Vaso-occlusive Crisis

Drugs mentioned

• intranasal sufentanil (sufentanil)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Vaso-occlusive Crisis | Phase 3 | Status: NOT_YET_RECRUITING